57.60
+0.69(+1.21%)
Currency In USD
Previous Close | 56.91 |
Open | 57.25 |
Day High | 57.74 |
Day Low | 56.46 |
52-Week High | 103.81 |
52-Week Low | 47.04 |
Volume | 535,000 |
Average Volume | 971,800 |
Market Cap | 3.19B |
PE | -34.08 |
EPS | -1.69 |
Moving Average 50 Days | 57.36 |
Moving Average 200 Days | 71 |
Change | 0.69 |
If you invested $1000 in PROCEPT BioRobotics Corporation (PRCT) since IPO date, it would be worth $1,373.39 as of July 01, 2025 at a share price of $57.6. Whereas If you bought $1000 worth of PROCEPT BioRobotics Corporation (PRCT) shares 3 years ago, it would be worth $1,837.91 as of July 01, 2025 at a share price of $57.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
GlobeNewswire Inc.
Apr 29, 2025 8:03 PM GMT
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that members o
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
GlobeNewswire Inc.
Apr 24, 2025 8:03 PM GMT
Presentations underscore long-term clinical outcomes, safety and durability in BPH treatment Attendees invited to experience hands-on HYDROS Robotic System demonstrations SAN JOSE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Co
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
GlobeNewswire Inc.
Apr 10, 2025 8:03 PM GMT
SAN JOSE, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company, whose mission is to revolutionize BPH treatment globally, announced today it will host an in-person in